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S U M M A R Y
A case of onychomycosis caused by Trichosporon mucoides in a man with diabetes is presented. The
infection was characterized by a brown–black pigmentation of the nail plates and subungual
hyperkeratosis of the ﬁrst three toes of both feet. Onychogryphosis was also visible on the third left toe.
Direct microscopic examinations revealed wide and septate hyphae and spores. Three cultures on
Sabouraud–gentamicin–chloramphenicol 2 agar and chromID Candida agar produced white, creamy,
and smooth colonies that were judged to be morphologically typical of T. mucoides. Microscopic
examinations of the colonies showed arthroconidia and blastoconidia. The urease test was positive. A
sugar assimilation test on yeast nitrogen base agar showed assimilation of galactitol, sorbitol, and
arabinitol. Matrix-assisted laser desorption/ionization time-of-ﬂight mass spectrometry (MALDI-TOF)
conﬁrmed the diagnosis of T. mucoides infection. The patient was treated with topical urea and oral
itraconazole. Three months later, a mild improvement was observed. The patient was subsequently lost
to follow-up.
 2015 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
nc-nd/4.0/).
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Trichosporon spp are yeast-like fungi found in soil and water.
Furthermore, they belong to the normal ﬂora of the human skin
and gastrointestinal tract.1,2 The ﬁrst case of onychomycosis
caused by Trichosporon mucoides was published in 2011 by
Sageerabanoo et al.1 An additional case was published in
2015 by Capoor et al.2 Both patients were Indian. To the authors’
knowledge, no other cases have been reported. A case of
onychomycosis caused by T. mucoides in a patient with diabetes
is presented here.
2. Case report
A 76-year-old Caucasian man was admitted because of
onychodystrophy of the toes. The patient stated that he was
being treated with metformin for type II diabetes. He also declared
that the onychodystrophy had appeared approximately 7 years
earlier.* Corresponding author. Tel.: +39 02 55035109; fax: +39 02 50320779.
E-mail address: stefano.veraldi@unimi.it (S. Veraldi).
http://dx.doi.org/10.1016/j.ijid.2015.11.011
1201-9712/ 2015 The Authors. Published by Elsevier Ltd on behalf of International So
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Dermatological examination revealed a brown–black pigmen-
tation of the nail plates and subungual hyperkeratosis of the ﬁrst
three toes of both feet. Onychogryphosis was also visible on the
third left toe (Figure 1).
A general physical examination did not reveal anything
pathological. Laboratory tests showed hyperglycemia (136 mg/
dl) and an increase in urea (56 mg/dl). Three direct microscopic
examinations of nail clippings, previously prepared with 30%
potassium hydroxide, revealed wide and septate hyphae and
spores. Three cultures on Sabouraud–gentamicin–chlorampheni-
col 2 agar (SGC2) and chromID Candida agar (CAN2) produced
white, creamy and smooth colonies within a few days, which were
judged to be morphologically typical of T. mucoides (Figure 2).
Microscopic examinations of the colonies showed arthroconidia
and blastoconidia. All cultures were negative for dermatophytes.
The urease test was positive. A sugar assimilation test on yeast
nitrogen base agar showed assimilation of galactitol, sorbitol, and
arabinitol. Matrix-assisted laser desorption/ionization time-of-
ﬂight mass spectrometry (MALDI-TOF MS) conﬁrmed the diagnosis
of T. mucoides infection (bionumber 6376777777377771). Three
bacteriological examinations were negative. In accordance with
the criteria of English3 and Gupta et al.,4 the ﬁnal diagnosis was
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Figure 1. Brown–black pigmentation of the nail plates and subungual
hyperkeratosis of the ﬁrst three toes of the left foot.
G. Rizzitelli et al. / International Journal of Infectious Diseases 42 (2016) 61–6362The patient was treated with 40% urea cream and oral
itraconazole. The latter was chosen because of his previous history
of urticaria caused by terbinaﬁne. Three months later, a mild
improvement was observed. The patient was subsequently lost to
follow-up.
3. Discussion
In the 1990s, it was observed that T. mucoides was sometimes
responsible for white piedra.5,6 Previously, white piedra was
considered to be caused by Trichosporon beigelii. Subsequently,
this species was divided into six distinct species: Trichosporon
asahii, Trichosporon asteroides, Trichosporon cutaneum, Trichos-
poron inkin, T. mucoides, and Trichosporon ovoides.5 T. mucoides is
currently included in the clade of T. cutaneum. White piedra had not
been described in tropical regions of Africa until a study carried out
in Libreville (Gabon) showed that the incidence of this infection was
rather high (18%) in a female population aged 15–60 years, with aFigure 2. White creamy and smooth colonies of Trichosporon mucoides.predominance in young patients (15–44 years). Fifty-two Trichos-
poron strains were isolated from pubic hairs and inguinal folds.
Three species were recognized: T. mucoides (25 strains), T. inkin
(20 strains), and T. asahii (seven strains).6,7 The identity of these
strains was conﬁrmed by means of an agglutination method
performed with monospeciﬁc antisera. This method allowed the
veriﬁcation of the presence of antigens common to the genera
Cryptococcus and Trichosporon.8 One additional case of white piedra
of the scalp caused by T. mucoides has been described in India.9
Trichosporon mucoides has also been responsible for severe
cases of deep infections in premature newborns,10,11 heart, kidney,
and liver transplant recipients,12,13 patients with acute lympho-
blastic leukemia,14 patients on peritoneal dialysis,15 and patients
with diabetes mellitus.16 The main reported risk factors for T.
mucoides invasive infections are antibiotic therapy, admission to
an intensive care unit, and the presence of a central venous
catheter.11 According to Capoor et al.,2 predisposing factors are
genetic abnormalities, old age, low socioeconomic level, climatic
conditions, hyperhydrosis, atherosclerosis, diabetes, immunodeﬁ-
ciency, and trauma.
No therapeutic guidelines exist for systemic T. mucoides
infections. In a study published in 2004, all species were
susceptible to amphotericin B.11 Resistance to itraconazole and
ﬂuconazole was observed in 4% and 6% of cases, respectively.11 The
in vitro activity of amphotericin B, ﬂuconazole, itraconazole, and
voriconazole against 27 clinical isolates of Trichosporon spp (14 T.
mucoides and 13 T. asahii), using the National Committee for
Clinical Laboratory Standards (NCCLS) M27-A2 reference micro-
dilution, Etest, and disk diffusion methods, was determined in a
study published in 2005.17 With the microdilution and Etest
methods, Trichosporon sp demonstrated relatively high minimum
inhibitory concentrations (MICs) for ﬂuconazole (MIC90 4 and
6 mg/ml, respectively) and relatively low MICs for voriconazole
(MIC90 0.125 and 0.125 mg/ml, respectively). MICs for amphoteri-
cin B determined on antibiotic medium 3 were lower (MIC90
0.06 mg/ml) than those on Roswell Park Memorial Institute (RPMI)
medium (MIC90 1 mg/ml).
17
In the same year, another study evaluated the in vitro activity of
combinations of micafungin with amphotericin B or ﬂuconazole,
itraconazole, ravuconazole, and voriconazole against isolates of
Trichosporon spp. Ten isolates of T. asahii and two of T. mucoides
were tested. Drug interactions were assessed by the checkerboard
technique using the NCCLS M27-A2 microdilution method. The
fractional inhibitory concentration index (FICI) was used to classify
drug interactions. Results were interpreted as follows: synergy,
FICI 0.5; no interaction, FICI >0.5 and 4.0; or antagonism, FICI
>4.0. Micafungin combined with amphotericin B showed the
highest percentage of synergic interactions (78%), followed by
micafungin/itraconazole and micafungin/ravuconazole (48% for
each), and micafungin/ﬂuconazole and micafungin/voriconazole
(34% for each).18
The isolates from the patient reported by Capoor et al.2 showed
resistance to ﬂuconazole (MIC 256 mg/ml), itraconazole (MIC
32 mg/ml), and voriconazole (MIC 32 mg/ml), and sensitivity to
amphotericin B (MIC 0.32 mg/ml) and terbinaﬁne (MIC 0.125 mg/
ml) (the patient was treated with terbinaﬁne). A heart and kidney
transplant recipient was successfully treated with oral ﬂucona-
zole;12 a liver transplant recipient was successfully treated with
posaconazole;13 a boy with acute lymphoblastic leukemia was
successfully treated with lipid complex amphotericin B and 5-
ﬂuorocytosine.14
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